Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05728008
Status:
COMPLETED
Last Update Posted:
2023-02-14
First Post:
2023-01-30
Brief Title:
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis
Sponsor:
IRCCS San Raffaele
Organization:
IRCCS San Raffaele
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-30
First Submit QC Date:
February 13 2023
Study First Post Date:
2023-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-13
Last Update Post Date:
2023-02-14
Last Update Post Date Type:
ACTUAL